Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Find the perfect cards to make your season’s greetings go even further. Every pack purchased will help fund vital research and support for people living with type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Inside the First Breakthrough T1D Clinical & Research Congress
The science, innovation and passion was inspiring. From early detection and disease-modifying therapies to clinical trials, advances in technology, cell therapy and clinical care, there was such a sense of momentum throughout the CRC.
A key topic of conversation throughout was what still needs to be built in type 1 care: screening for early-stage T1D as standard; disease-modifying therapies as a standard offer to every eligible patient at every stage; and clinical trials built for people, with something for everyone.
There were a number of presentations on early detection from around the world, including numerous researchers and clinicians in the UK. It was great to hear how screening programmes and pilots were going in Australia, Italy and the US, and provided a lot of food for thought about how we should proceed with early detection in the UK.
The need to build a culture of clinical trial participation was discussed at numerous sessions, with less than 1% of those with T1D currently taking part in a trial. The Congress presented lots of data from clinical trials, including exciting summaries of progress in major trials in cell therapies and disease-modifying therapies, as well as many smaller studies presented in the fantastic short oral sessions in the exhibition area.
There was a real appreciation for the vital role of people who live with T1D in participating in and designing clinical trials. Multiple sessions included a call to ensure that presenting options to participate in research studies is provided to people as part of routine care. Many speakers focussed on learning from the cancer field, where clinical teams have the information they need to help everyone feel comfortable and confident discussing research studies as a genuine choice, available to all.
CRC had a tangible sense of excitement and purpose around driving forward cell therapy for T1D. From sessions focussed on cutting edge discovery science allowing us to understand how to manufacture insulin-producing cells, to conversations about creating coordinated clinical networks to ensure equal access to cell therapies for all. Every talk seemed to build further momentum.
While there are still many questions to answer, the future for cell therapies in T1D feels bright and filled with potential.
Putting patient and family choice at the heart of T1D research and care was a key theme of the CRC. The ability to do this is constantly improving due to the range of options becoming available around the world, such as early detection and disease-modifying therapies.
What always makes these events so special is the people. Seeing the global T1D community come together to share ideas, challenge thinking, learn from one another and build new connections is a powerful reminder of what’s possible when expertise, lived experience and a shared sense of purpose come together.
We’re incredibly proud to be part of the global Breakthrough T1D family, focused solely on T1D and committed to improving everyday life for people living with the condition while driving progress towards cures.
Find out how early detection works, why it matters, and how you can access screening for yourself, your child or someone you care for.
Dealing with type 1 every day can have an emotional impact, whether you’re newly diagnosed or have been living with type 1 for some time.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
A new international position statement says people with diabetes should often be able to keep using continuous glucose monitors, insulin pumps and hybrid closed loop systems during a hospital stay, as long as it is safe and appropriate.
We look at a new feature coming to the CamAPS FX app, which will allow users to remove the need to count carbohydrates before a meal.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Researchers from John Hopkins University, USA, partially funded by Breakthrough T1D, have developed an experimental treatment that protects the insulin-producing cells from inflammatory damage, allowing them to survive for longer in animal models.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?
